Evoke Pharma Price to Sales Ratio 2012-2024 | EVOK
Historical PS ratio values for Evoke Pharma (EVOK) over the last 10 years. The current P/S ratio for Evoke Pharma as of November 01, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Evoke Pharma P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-11-01 |
5.80 |
|
0.37 |
| 2024-06-30 |
6.35 |
$15.79 |
0.40 |
| 2024-03-31 |
7.32 |
$17.98 |
0.41 |
| 2023-12-31 |
12.60 |
$18.59 |
0.68 |
| 2023-09-30 |
16.56 |
$15.62 |
1.06 |
| 2023-06-30 |
19.80 |
$12.99 |
1.52 |
| 2023-03-31 |
22.80 |
$10.69 |
2.13 |
| 2022-12-31 |
32.16 |
$9.62 |
3.34 |
| 2022-09-30 |
22.44 |
$8.20 |
2.74 |
| 2022-06-30 |
38.88 |
$9.33 |
4.17 |
| 2022-03-31 |
71.28 |
$8.62 |
8.26 |
| 2021-12-31 |
79.20 |
$7.20 |
10.99 |
| 2021-09-30 |
187.20 |
$5.59 |
33.49 |
| 2021-06-30 |
197.28 |
$1.47 |
134.15 |
| 2021-03-31 |
263.52 |
$0.42 |
630.23 |
| 2020-12-31 |
371.52 |
0 |
0.00 |
| 2020-09-30 |
675.36 |
0 |
0.00 |
| 2020-06-30 |
509.76 |
0 |
0.00 |
| 2020-03-31 |
167.04 |
0 |
0.00 |
| 2019-12-31 |
233.28 |
0 |
0.00 |
| 2019-09-30 |
123.84 |
0 |
0.00 |
| 2019-06-30 |
90.00 |
0 |
0.00 |
| 2019-03-31 |
216.00 |
0 |
0.00 |
| 2018-12-31 |
357.12 |
0 |
0.00 |
| 2018-09-30 |
429.12 |
0 |
0.00 |
| 2018-06-30 |
360.00 |
0 |
0.00 |
| 2018-03-31 |
299.52 |
0 |
0.00 |
| 2017-12-31 |
325.44 |
0 |
0.00 |
| 2017-09-30 |
480.96 |
0 |
0.00 |
| 2017-06-30 |
368.44 |
0 |
0.00 |
| 2017-03-31 |
446.40 |
0 |
0.00 |
| 2016-12-31 |
290.88 |
0 |
0.00 |
| 2016-09-30 |
325.44 |
0 |
0.00 |
| 2016-06-30 |
986.40 |
0 |
0.00 |
| 2016-03-31 |
732.96 |
0 |
0.00 |
| 2015-12-31 |
475.20 |
0 |
0.00 |
| 2015-09-30 |
419.04 |
0 |
0.00 |
| 2015-06-30 |
753.12 |
0 |
0.00 |
| 2015-03-31 |
1015.20 |
0 |
0.00 |
| 2014-12-31 |
849.60 |
0 |
0.00 |
| 2014-09-30 |
791.93 |
0 |
0.00 |
| 2014-06-30 |
1164.96 |
0 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.005B |
$0.005B |
|
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
|
